PAR-1 contributes to the innate immune response during viral infection.
暂无分享,去创建一个
D. Kirchhofer | J. Luyendyk | N. Mackman | J. Trejo | R. Pawlinski | D. Esserman | A. P. Owens | M. Beck | B. Blaxall | U. Rauch | S. Antoniak | P. Sheridan | Julie C. Williams | M. Baunacke | Ronny Malz | A. Weithäuser | R. D. Lee | Rebecca D. Lee
[1] P. Carmeliet,et al. PAR1 contributes to influenza A virus pathogenicity in mice. , 2013, The Journal of clinical investigation.
[2] N. Mackman,et al. &bgr;-Adrenergic Receptor Stimulation Transactivates Protease-Activated Receptor 1 via Matrix Metalloproteinase 13 in Cardiac Cells , 2012, Circulation.
[3] H. Fechner,et al. Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis. , 2012, Journal of molecular and cellular cardiology.
[4] W. Ruf,et al. Tissue factor and glycoprotein C on herpes simplex virus type 1 are protease-activated receptor 2 cofactors that enhance infection. , 2012, Blood.
[5] Marc P. Bonaca,et al. Vorapaxar in the secondary prevention of atherothrombotic events. , 2012, The New England journal of medicine.
[6] S. Vogel,et al. Proteinase-activated receptor 2 activation promotes an anti-inflammatory and alternatively activated phenotype in LPS-stimulated murine macrophages , 2012, Innate immunity.
[7] E. Lien,et al. Toll-like receptor 3-elicited MAPK activation induces stabilization of interferon-β mRNA. , 2012, Cytokine.
[8] D. Johns,et al. Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. , 2012, The Journal of clinical investigation.
[9] Giuseppe Ambrosio,et al. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. , 2012, The New England journal of medicine.
[10] N. Mackman,et al. Effect of PAR-2 Deficiency in Mice on KC Expression after Intratracheal LPS Administration , 2011, Journal of signal transduction.
[11] W. Mitzner,et al. Th2 Regulation of Viral Myocarditis in Mice: Different Roles for TLR3 versus TRIF in Progression to Chronic Disease , 2011, Clinical & developmental immunology.
[12] A. Norrby-Teglund,et al. Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. , 2011, Blood.
[13] C. Esmon,et al. Innate immunity and coagulation , 2011, Journal of Thrombosis and Haemostasis.
[14] D. Knight,et al. Granzyme K Activates Protease-Activated Receptor-1 , 2011, PloS one.
[15] N. Mackman,et al. Protease‐activated receptors and myocardial infarction , 2011, IUBMB life.
[16] S. Felix,et al. TRIF Is a Critical Survival Factor in Viral Cardiomyopathy , 2011, The Journal of Immunology.
[17] N. Mackman,et al. Protease-Activated Receptor 2 Deficiency Reduces Cardiac Ischemia/Reperfusion Injury , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[18] J. Towbin,et al. A Role for Toll-like Receptor 3 Variants in Host Susceptibility to Enteroviral Myocarditis and Dilated Cardiomyopathy* , 2010, The Journal of Biological Chemistry.
[19] Michael R Dores,et al. Signal transduction by protease‐activated receptors , 2010, British journal of pharmacology.
[20] A. Fasano,et al. Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo , 2010, Mucosal Immunology.
[21] Y. Laumonnier,et al. Human cytomegalovirus increases HUVEC sensitivity to thrombin and modulates expression of thrombin receptors , 2010, Journal of Thrombosis and Thrombolysis.
[22] M. Lederman,et al. Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. , 2010, Blood.
[23] Leon Poller,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[24] S. Riffault,et al. Protective Role for Protease-Activated Receptor-2 against Influenza Virus Pathogenesis via an IFN-γ-Dependent Pathway1 , 2009, The Journal of Immunology.
[25] P. Cohen,et al. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. , 2009, The Journal of biological chemistry.
[26] W. Poller,et al. Regulation of cardiomyocyte full‐length tissue factor expression and microparticle release under inflammatory conditions in vitro , 2009, Journal of thrombosis and haemostasis : JTH.
[27] Ji-yuan,et al. CXCL10 Inhibits Viral Replication Through Recruitment of Natural Killer Cells in Coxsackievirus B3-Induced Myocarditis , 2009 .
[28] K. Preissner,et al. A key role for Toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells. , 2009, Blood.
[29] M. Richer,et al. Toll-Like Receptor 3 Signaling on Macrophages Is Required for Survival Following Coxsackievirus B4 Infection , 2009, PloS one.
[30] T. Seya,et al. Functional evolution of the TICAM‐1 pathway for extrinsic RNA sensing , 2009, Immunological reviews.
[31] K. Honda,et al. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity , 2008, Proceedings of the National Academy of Sciences.
[32] E. Kroon,et al. Interferons: Signaling, antiviral and viral evasion , 2008, Immunology Letters.
[33] M. Hollenberg,et al. Analysis of Proteinase-activated Receptor 2 and TLR4 Signal Transduction , 2008, Journal of Biological Chemistry.
[34] R. Lechler,et al. Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1–dependent leukocyte recruitment in vivo , 2008, The Journal of experimental medicine.
[35] A. Dörner,et al. Viral myocarditis and coagulopathy: increased tissue factor expression and plasma thrombogenicity. , 2008, Journal of molecular and cellular cardiology.
[36] H. Rammensee,et al. Effective Chemokine Secretion by Dendritic Cells and Expansion of Cross-Presenting CD4−/CD8+ Dendritic Cells Define a Protective Phenotype in the Mouse Model of Coxsackievirus Myocarditis , 2008, Journal of Virology.
[37] M. Hollenberg,et al. Role of protease‐activated receptors in inflammatory responses, innate and adaptive immunity , 2008, Journal of leukocyte biology.
[38] Jorge Cime-Castillo,et al. Crosstalk between coagulation and inflammation during Dengue virus infection , 2008, Thrombosis and Haemostasis.
[39] B. McManus,et al. Ablation of Matrix Metalloproteinase-9 Increases Severity of Viral Myocarditis in Mice , 2008, Circulation.
[40] E. Turpin,et al. STAT-1 Signaling in Human Lung Fibroblasts Is Induced by Vanadium Pentoxide through an IFN-β Autocrine Loop1 , 2008, The Journal of Immunology.
[41] F. Bistoni,et al. The contribution of PARs to inflammation and immunity to fungi , 2008, Mucosal Immunology.
[42] M. Steinhoff,et al. Protease-activated receptors: novel PARtners in innate immunity. , 2007, Trends in immunology.
[43] T. Luther,et al. Protease-Activated Receptor-1 Contributes to Cardiac Remodeling and Hypertrophy , 2007, Circulation.
[44] N. Mackman,et al. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[45] T. Bugge,et al. Fibrin and fibrinolysis in infection and host defense , 2007, Journal of thrombosis and haemostasis : JTH.
[46] M. Beck,et al. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. , 2007, The Journal of nutrition.
[47] H. Friedman,et al. Thrombin enhances herpes simplex virus infection of cells involving protease‐activated receptor 1 , 2007, Journal of thrombosis and haemostasis : JTH.
[48] A. Hsu,et al. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts , 2007, Basic Research in Cardiology.
[49] M. Halks-Miller,et al. Antiviral and myocyte protective effects of murine interferon-beta and -{alpha}2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice. , 2007, American journal of physiology. Heart and circulatory physiology.
[50] Mustapha Si-Tahar,et al. Cutting Edge: Influenza A Virus Activates TLR3-Dependent Inflammatory and RIG-I-Dependent Antiviral Responses in Human Lung Epithelial Cells1 , 2007, The Journal of Immunology.
[51] Hongmin Sun,et al. The interaction between pathogens and the host coagulation system. , 2006, Physiology.
[52] A. Zell,et al. Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes. , 2006, The American journal of pathology.
[53] K. Conzelmann,et al. Viruses know it all: new insights into IFN networks. , 2005, Trends in immunology.
[54] F. Peale,et al. A monoclonal antibody that inhibits mouse tissue factor function , 2005, Journal of thrombosis and haemostasis : JTH.
[55] B. Sherry,et al. Basal and Reovirus-Induced Beta Interferon (IFN-β) and IFN-β-Stimulated Gene Expression Are Cell Type Specific in the Cardiac Protective Response , 2005, Journal of Virology.
[56] T. Standiford,et al. IP-10 mediates selective mononuclear cell accumulation and activation in response to intrapulmonary transgenic expression and during adenovirus-induced pulmonary inflammation. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[57] S. Steinberg. The Cardiovascular Actions of Protease-Activated Receptors , 2005, Molecular Pharmacology.
[58] L. Frati,et al. p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. , 2004, Blood.
[59] E. Fish,et al. Protective Role for Interferon-&bgr; in Coxsackievirus B3 Infection , 2004, Circulation.
[60] L. Rozek,et al. Plasminogen Is a Critical Host Pathogenicity Factor for Group A Streptococcal Infection. , 2004 .
[61] W. Ruf. Emerging roles of tissue factor in viral hemorrhagic fever. , 2004, Trends in immunology.
[62] N. Mackman. Role of tissue factor in hemostasis, thrombosis, and vascular development. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[63] G. Stewart,et al. Altered expression and in vivo lung function of protease-activated receptors during influenza A virus infection in mice. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[64] P. Jahrling,et al. Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. , 2003, The Journal of infectious diseases.
[65] A. Sabri,et al. Protease-Activated Receptor-1–Mediated DNA Synthesis in Cardiac Fibroblast Is via Epidermal Growth Factor Receptor Transactivation: Distinct PAR-1 Signaling Pathways in Cardiac Fibroblasts and Cardiomyocytes , 2002, Circulation research.
[66] S. Coughlin. Protease-activated Receptors in Vascular Biology , 2001, Thrombosis and Haemostasis.
[67] K. Klingel,et al. Cardioselective Infection With Coxsackievirus B3 Requires Intact Type I Interferon Signaling: Implications for Mortality and Early Viral Replication , 2001, Circulation.
[68] S. Coughlin,et al. Thrombin signalling and protease-activated receptors , 2000, Nature.
[69] H. Zhang,et al. Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors. , 2000, Circulation research.
[70] S. Kawabata,et al. Evolution and phylogeny of defense molecules associated with innate immunity in horseshoe crab. , 1998, Frontiers in bioscience : a journal and virtual library.
[71] P. A. Peterson,et al. Biological Consequences of Thrombin Receptor Deficiency in Mice , 1996, Thrombosis and Haemostasis.
[72] A. Naldini,et al. Thrombin modulation of natural killer activity in human peripheral lymphocytes. , 1996, Cellular Immunology.
[73] J. Hoffmann,et al. Innate immunity of insects. , 1995, Current opinion in immunology.
[74] T. Drake,et al. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. , 1993, The American journal of pathology.
[75] N. Mackman,et al. Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide , 1991, Molecular and cellular biology.
[76] C. Esmon,et al. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[77] D. Crossman,et al. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. , 1990, The Journal of biological chemistry.
[78] S. Gregory,et al. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin , 1989, Molecular and cellular biology.
[79] C. Gauntt,et al. Murine natural killer cells limit coxsackievirus B3 replication. , 1987, Journal of immunology.
[80] P. Hofschneider,et al. Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[81] T. Flægstad,et al. Increased Tissue Thromboplastin Activity in Monocytes of Patients with Meningococcal Infection: Related to an Unfavourable Prognosis , 1983, Thrombosis and Haemostasis.
[82] Hong Zhou,et al. Inhibition of clathrin/dynamin-dependent internalization interferes with LPS-mediated TRAM-TRIF-dependent signaling pathway. , 2012, Cellular immunology.
[83] R. Flavell,et al. Novel antagonist antibody to TLR3 blocks poly(I:C)-induced inflammation in vivo and in vitro. , 2011, Cellular immunology.
[84] T. Poll,et al. Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study , 2010, Critical care.
[85] B. McManus,et al. Matrix metalloproteinases in the pathogenesis of viral heart disease. , 2009, Trends in cardiovascular medicine.
[86] G. Sen,et al. Interferons and viral infections , 2009, BioFactors.
[87] M. Halks-Miller,et al. Antiviral and myocyte protective effects of murine interferon-beta and -{alpha}2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice. , 2007, American journal of physiology. Heart and circulatory physiology.
[88] R. Flavell,et al. Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury. , 2007, American journal of physiology. Heart and circulatory physiology.
[89] J. Degen,et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. , 2005, Blood.
[90] B. Sherry,et al. Basal and reovirus-induced beta interferon (IFN-beta) and IFN-beta-stimulated gene expression are cell type specific in the cardiac protective response. , 2005, Journal of virology.
[91] H. Schultheiss,et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. , 2003, Circulation.
[92] H. Schultheiss,et al. Interferon- (cid:1) Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction , 2003 .
[93] C. Janeway,et al. Innate immune recognition. , 2002, Annual review of immunology.
[94] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[95] T. van der Poll,et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. , 1994, The Journal of clinical investigation.
[96] T. Drake,et al. Procoagulant Response of the Endothelium and Monocytes , 1993 .
[97] H. Redl,et al. Pathophysiology of Shock, Sepsis, and Organ Failure , 1993, Springer Berlin Heidelberg.
[98] F. Taylor,et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. , 1991, Circulatory shock.
[99] B. Osterud,et al. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. , 1983, Thrombosis and haemostasis.